USPlabs has invested heavily in clinical and analytical research on 1,3 DMAA. We made four submissions to FDA providing the most up to date information regarding the safety and legality of the ingredient. This included 11 peer-reviewed, published clinical and analytical studies.

Those submissions, including all appendices, can be viewed by clicking on the dates below: